Sulfamoyl benzamides as novel CB2 cannabinoid receptor ligands

Sulfamoyl benzamides as novel CB2 cannabinoid receptor ligands Discovery of N-(3-(morpholinomethyl)-phenyl)-amides as potent and selective CB2 agonists CB2 selective sulfamoyl benzamides: Optimization of the amide functionality Novel sulfenamides and sulfonamides based on pyridazinone and pyridazine scaffolds as CB 1 receptor ligand antagonists Novel pyridine derivatives as potent and selective CB2 cannabinoid receptor agonists 5-Sulfonyl-benzimidazoles as selective CB2 agonists-Part 2 Novel benzimidazole derivatives as selective CB2 agonists Arylsulfonamides as a new class of cannabinoid CB1 receptor ligands: Identification of a lead and initial SAR studies New Resorcinol−Anandamide “Hybrids” as Potent Cannabinoid Receptor Ligands Endowed with Antinociceptive Activity in Vivo New 1,8-naphthyridine and quinoline derivatives as CB2 selective agonists